Prof Strange flagged at the end of May that they might get a follow up question from FDA, which they did get, and that even so he expected at best a 30 day turnaround for the extra questions. In the quarterly they indicated they still expected a decision by the FDA before the end of September.
FDA approval, should they get it, would be an inflection point for this company. My impression is that the top team are mainly marketing and sales guys, not techos, so from now on is the time they need to strut their stuff. Also in the end of May presentation they said that their US sales agent, Cassling, have 45 salesmen ready to go to work once the FDA clearance comes through.
I would be excited but I've had so many disappointments with companies failing to successfully transitioning into operators. Plus the current market is such a dog. I'll be content if they get FDA approval and the share price does not consequently tank.
EIQ Price at posting:
15.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)